West Pharmaceutical CEO Eric Green to Retire in 2026, Board Launches Succession Search
Event summary
- Eric M. Green, CEO of West Pharmaceutical Services, plans to retire in the second half of 2026 after 11 years in the role.
- The Board of Directors has engaged an executive recruiting firm to find a successor.
- Green's tenure saw revenue more than double and total shareholder return of approximately 350%.
- The company reaffirmed its guidance from February 12, 2026, alongside the announcement.
The big picture
West Pharmaceutical Services is navigating a leadership transition at a time when the pharmaceutical services sector is under pressure to innovate and scale. The company's strong financial performance under Green's leadership sets a high bar for the incoming CEO, who will need to manage both internal continuity and external market dynamics. The succession process will be closely watched by investors and industry peers.
What we're watching
- Leadership Continuity
- How the new CEO will maintain the company's growth momentum and strategic direction.
- Market Position
- Whether West can sustain its leadership in injectable solutions amid increasing competition.
- Operational Stability
- The pace at which the transition will impact day-to-day operations and long-term projects.
Related topics